Company news

Pacific Biosciences of California, Inc. news in 2022

Pacific Biosciences of California, Inc.'s news releases, calls and decks from 2022, newest first.

View company

PacBio to Present at 41st Annual J.P. Morgan Healthcare Conference

December 27, 2022

PacBio and Boston Children's Hospital Collaborate to Investigate Novel Variants Inaccessible by Short-Read Sequencing

December 5, 2022

PacBio Announces Third Quarter 2022 Financial Results

November 6, 2022

PacBio Announces that Euan Ashley, M.D., Ph.D., Joseph Puglisi, Ph.D., and Jay Shendure, Ph.D., Join Newly Created Scientific Advisory Board

November 1, 2022

PacBio to Report Third Quarter Earnings on November 7 and Host Inaugural Investor Day on November 15

October 24, 2022

PacBio Announces Revio, a Revolutionary New Long Read Sequencing System Designed to Provide 15 Times More HiFi Data and Human Genomes at Scale for Under $1,000

October 24, 2022

PacBio Announces Onso, the Highly Accurate Short-Read Sequencing Platform

October 24, 2022

PacBio Launches Single-Cell Transcriptome Solution Ushering in a New Era of RNA Discovery

October 19, 2022

PacBio and Twist Bioscience Deliver Initial Portfolio of Target Enrichment Panels for HiFi Sequencing

October 18, 2022

PacBio Collaborates with Leading Researchers to Establish Long-Read Variant Frequency Consortium

October 17, 2022

PacBio Unveils a New Method for Comprehensive, Genome-wide Tandem Repeat Analysis

September 26, 2022

PacBio to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

September 6, 2022

PacBio to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit

August 4, 2022

PacBio Announces Second Quarter 2022 Financial Results

August 2, 2022

PacBio Announces Appointment of Genomics Industry Veteran Jeff Eidel as Chief Commercial Officer

July 20, 2022

PacBio to Report Second Quarter 2022 Financial Results on August 3, 2022

July 17, 2022

PacBio to Participate in the BofA Securities 2022 Healthcare Conference

May 4, 2022

PacBio Announces First Quarter 2022 Financial Results

May 3, 2022

PacBio transforms access to the epigenome and streamlines workflows

April 20, 2022

PacBio and Children’s Mercy Kansas City Expand Collaboration Taking a Multi-Omics Approach to Characterize Rare Disease

April 20, 2022

PacBio to Report First Quarter 2022 Financial Results on May 4, 2022

April 19, 2022

PacBio Enters Agricultural Industry Collaboration with Corteva Agriscience to Develop High-Throughput Plant, Pest and Microbial Sequencing

April 3, 2022

HiFi Reads Enable Telomere-to-Telomere Consortium to Fill the Final Gaps in the Human Genome, Heralding a New Era of Research into Genetic Diseases and Human Biology

March 30, 2022

PacBio Opens European Headquarters in London

March 22, 2022

PacBio Supports SickKids to Investigate Use of HiFi Sequencing in Undiagnosed Genetic Conditions

February 27, 2022

PacBio Welcomes Dr. Michael Eberle as Vice President of Computational Biology

February 22, 2022

KK Women’s and Children’s Hospital and PacBio Collaborate in Asia’s First Study of Unexplained Neurodevelopmental Disorders

February 15, 2022

PacBio Announces Fourth Quarter and Fiscal Year 2021 Financial Results

February 14, 2022

PacBio to Report Fourth Quarter and Full Year 2021 Financial Results on February 15, 2022

January 31, 2022

PacBio Names Lara Toerien as Vice President and General Manager for the Americas

January 12, 2022

PacBio Announces Record Preliminary Fourth Quarter 2021 Revenue, New Sequencing Kits and Workflows, and Expanded Collaborations

January 10, 2022

PacBio Announces Collaboration with Genomics England to Sequence Biobanked Rare Disease Samples Using HiFi Sequencing Technology

January 10, 2022

PacBio and Google Collaborate to Use Machine Learning to Optimize Long-Read Sequencing Data Analysis

January 10, 2022

PacBio and Berry Genomics Announce Collaboration to Bring Long Read Desktop Sequencing Instrument to the Clinical Market in China

January 10, 2022

Radboud University Medical Center Increases HiFi Sequencing Capacity with PacBio’s Sequel IIe

January 6, 2022

PacBio and Care4Rare Consortium Collaborate on Rare Disease Research Study

January 4, 2022

PacBio to Present at Upcoming Investor Conference

January 3, 2022

Calls in 2022

Decks in 2022